Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-28FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to add an intravenous formulation of pantoprazole (PROTONIX I.V.) from Wyeth Pharmaceuticals (Pf…
-
FDA approval · 2012-09-28FDA Approved: PANTOPRAZOLE SODIUM — Original Application (NorthStar Rx LLC)
FDA approves Pantoprazole sodium from NorthStar Rx LLC as an Original Application (ANDA), making a generic proton pump inhibitor available f…
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study [Phase 4]
A Phase 4 pilot trial evaluates how timing affects the efficacy of Zegerid 40 mg in healing erosive esophagitis, with results posted.
-
FDA approval · 2012-09-10FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for GOOD NEIGHBOR PHARMACY OMEPRAZOLE (omeprazole) under NDA 022032, with Amerisource Bergen as the …
-
FDA approval · 2012-09-07FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Pantoprazole sodium from Mylan Pharmaceuticals Inc., continuing approval for this generic produc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-08-27FDA Approved: OMEPRAZOLE MAGNESIUM — Supplemental Application (Gericare Pharmaceuticals)
FDA approved a supplemental application for Omeprazole Magnesium by Gericare Pharmaceuticals under ANDA078878, approving the changes describ…
-
FDA approval · 2012-06-13FDA Approved: FAMOTIDINE — Supplemental Application (Carlsbad Technology, Inc)
FDA approved a supplemental application for famotidine from Carlsbad Technology, Inc.
-
FDA label_change · 2012-05-18FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Pantoprazole Sodium (Lannett Company) under ANDA 078281, signaling changes to the labeling f…
-
FDA approval · 2012-05-18FDA Approved: BASIC CARE LANSOPRAZOLE — Original Application (Amazon.com Services LLC)
FDA approved a generic lansoprazole product, BASIC CARE LANSOPRAZOLE, under an original application by Amazon.com Services LLC. This provide…
-
FDA approval · 2012-05-18FDA Approved: LANSOPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for lansoprazole from Dr. Reddy's Laboratories, authorizing a generic lansoprazole product.
-
FDA approval · 2012-05-11FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-05-10FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX I.V. (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-05-08FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for ACIPHEX (rabeprazole sodium).
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342) [Phase 4]
Phase 4 clinical trial updating a comparison of healing concepts after pantoprazole treatment in adults with erosive gastroesophageal reflux…
-
FDA approval · 2012-04-19FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for an omeprazole and sodium bicarbonate product, updating its labeling…
-
FDA approval · 2012-04-18FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for lansoprazole, authorizing the marketing of a generic lansoprazole…
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
FDA approval · 2012-03-23FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approves Apotex Corp's supplemental application for omeprazole (generic) under ANDA076048. This authorizes the marketing of a generic om…
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
-
FDA approval · 2012-02-13FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole submitted by Sandoz Inc under ANDA075757 (generic omeprazole).
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
CLINICAL_TRIALS trial_result · 2012-02-02Clinical Trial Update: Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of ilaprazole at 5, 20 and 40 mg daily and lansoprazole 30 mg daily for healing erosive esophag…
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.